Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 14/20 | 0.41 |
| ▸ | CALCR | P30988 | 14/20 | 0.41 |
| ▸ | APLNR | P35414 | 1/20 | 0.41 |
| ▸ | GRB2 | P62993 | 1/20 | 0.40 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.40 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.40 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16330316 | 0.90 | RAMP3 (0.45) | RAMP3CALCRGRB2 | |
| SCHEMBL12314880 | 0.84 | RAMP3 (0.47) | RAMP3CALCRGRB2 | |
| SCHEMBL12314876 | 0.84 | RAMP3 (0.47) | RAMP3CALCRGRB2 | |
| SCHEMBL13084645 | 0.84 | RAMP3 (0.47) | RAMP3CALCRGRB2 | |
| SCHEMBL13084700 | 0.84 | RAMP3 (0.47) | RAMP3CALCRGRB2 | |
| SCHEMBL14452355 | 0.80 | GRB2 (0.45) | RAMP3CALCRGRB2CAPN1 | |
| SCHEMBL12339085 | 0.80 | RAMP3 (0.46) | RAMP3CALCRGRB2CAPN1 | |
| SCHEMBL16351204 | 0.80 | RAMP3 (0.46) | RAMP3CALCRGRB2CAPN1 | |
| SCHEMBL16351202 | 0.79 | OPRM1 (0.49) | RAMP3CALCRGRB2CAPN1 | |
| SCHEMBL16340685 | 0.77 | GRB2 (0.49) | APLNRGRB2CAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263739-B2 | also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis | BRACCO SUISSE SA (CH) | 2012-09-11 | — | — | US | disclosed |